Erlotinib intermediates manufacturer
|
PRODUCT DESCRIPTION |
|
Prodcut name |
Lenvatinib |
|
Synonyms |
4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide |
|
MOQ |
1kg |
|
CAS No. |
417716-92-8 |
|
Appearance |
White or off- white crystalline powder |
|
Molecular Formula |
C21H19ClN4O4 |
|
Molecular Weight |
426.85 |
|
Assay |
99% |
|
Application |
Pharma grade or research purpose |
|
Packing |
As per your request |
|
Storage |
Preserve in tight,light-resistant containers in a cool place |
|
Remarks |
NA |
|
Custom synthesis |
Available |
|
Supply Ability |
50kg/month |
Lenvatinib is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
SupplyAbility
100 Kilogram/Kilograms per Month
Packaging & Delivery
10g,100g, 1kg Aluminum Foil bag/25kg drum/ bottle or negotiation
Port
Any port in China
Lead Time :
within 3 working days after payment
